Enterprise Therapeutics Revenue

Pharmaceutical Manufacturing • Brighton, England, United Kingdom • 11-20 Employees

Enterprise Therapeutics revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$84,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$3,200,000
Total funding	$40,400,000

Key Contacts at Enterprise Therapeutics

Rob Woodman

Non Executive Director

Peter Finan

Director

Company overview

Headquarters	University of Sussex, Science Park Square, Brighton, East Sussex BN1 9SB, GB
Phone number	+441273234667
Website	enterprisetherapeutics.com
NAICS	3254
SIC	873
Keywords	Drug Development, Drug Discovery, Medicinal Chemistry, Cystic Fibrosis, Epithelial Cell Biology, Ion Channel Pharmacology
Founded	2014
Employees	11-20
Socials

Enterprise Therapeutics Email Formats

Enterprise Therapeutics uses 1 email format. The most common is {first initial} (e.g., j@enterprisetherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@enterprisetherapeutics.com	100%

About Enterprise Therapeutics

Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. The company benefits from a close working relationship with the School of Life Sciences at the University of Sussex.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Head

Director

Manager

Employees by Department

Enterprise Therapeutics has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Enterprise Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-11-15	9	$7,300,000
2024-02-29	5	$33,100,000

Funding Insights

$40,400,000

Total funding amount

$33,100,000

Most recent funding amount

Number of funding rounds

Enterprise Therapeutics Tech Stack

Discover the technologies and tools that power Enterprise Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

lit-element

JavaScript libraries

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

WordPress

Blogs

YouTube

Video players

Frequently asked questions

Enterprise Therapeutics is located in Brighton, England, GB.

You can reach Enterprise Therapeutics at +441273234667.

Enterprise Therapeutics generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Enterprise Therapeutics has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Enterprise Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

Enterprise Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Enterprise Therapeutics has raised a total of $40,400,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Enterprise Therapeutics

Rob Woodman

Non Executive Director

Peter Finan

Director

4.8

40,000 users